首页 / 院系成果 / 成果详情页

Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release  期刊论文  

  • 编号:
    59fc4afd-b223-43c2-853d-e75949f18a82
  • 作者:
    Ni, Yingmeng#[1,2]Hao, Jimin#[1,2]Hou, Xiaoxia#[1,2]Du, Wei[1,2];Yu, Youchao[1,2];Chen, Tiantian[1,2];Wei, Zhuang[3];Li, Yangyang[4];Zhu, Fuxiang[4];Wang, Shuaiwei[4];Liang, Rui[4];Li, Dan[4];Lu, Yue[5]Liao, Kan[3];Li, Bin*[4]Shi, Guochao*[1,2]
  • 语种:
    英文
  • 期刊:
    FRONTIERS IN IMMUNOLOGY ISSN:1664-3224 2018 年 9 卷 ; JUN 21
  • 收录:
  • 关键词:
  • 摘要:

    Background: Asthma is a chronic inflammatory disease characterized by airway inflammation and airway hyperresponsiveness (AHR). IL-33 is considered as one of the most critical molecules in asthma pathogenesis. IL-33 is stored in nucleus and passively released during necrosis. But little is known about whether living cells can release IL-33 and how this process is regulated.
    Objective: We sought to investigate the role of polymerase I and transcript release factor (PTRF) in IL-33 release and asthma pathogenesis.
    Methods: Ovalbumin (OVA)-induced asthma model in PTRF+/- mice were employed to dissect the role of PTRF in vivo. Then, further in vitro experiments were carried out to unwind the potential mechanism involved.
    Results: In OVA asthma model with challenge phase, PTRF+/- mice showed a greater airway hyper-reaction, with an intense airway inflammation and more eosinophils in bronchoalveolar lavage fluid (BALF). Consistently, more acute type 2 immune response in lung and a higher IL-33 level in BALF were found in PTRF+/- mice. In OVA asthma model without challenge phase, airway inflammation and local type 2 immune responses were comparable between control mice and PTRF+/- mice. Knockdown of PTRF in 16HBE led to a significantly increased level of IL-33 in cell culture supernatants in response to LPS or HDM. Immunoprecipitation assay clarified Y158 as the major phosphorylation site of PTRF, which was also critical for the interaction of IL-33 and PTRF. Overexpression of dephosphorylated mutant Y158F of PTRF sequestered IL-33 in nucleus together with PTRF and limited IL-33 extracellular secretion.
    Conclusion: Partial loss of PTRF led to a greater AHR and potent type 2 immune responses during challenge phase of asthma model, without influencing the sensitization phase. PTRF phosphorylation status determined subcellular location of PTRF and, therefore, regulated IL-33 release.

  • 推荐引用方式
    GB/T 7714:
    Ni Yingmeng,Hao Jimin,Hou Xiaoxia, et al. Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release [J].FRONTIERS IN IMMUNOLOGY,2018,9.
  • APA:
    Ni Yingmeng,Hao Jimin,Hou Xiaoxia,Du Wei,&Shi Guochao.(2018).Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release .FRONTIERS IN IMMUNOLOGY,9.
  • MLA:
    Ni Yingmeng, et al. "Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release" .FRONTIERS IN IMMUNOLOGY 9(2018).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:61 下载次数:0
浏览次数:61
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部